U.S. Should Continue Leadership Role, Make Strategic Investments In Foreign Aid, Global Health
The Hill: Ending AIDS requires U.S. investment
Mark Dybul, faculty co-director of the Center for Global Health and Quality and professor in the department of medicine at Georgetown University Medical Center, and Bill Frist, heart and lung transplant surgeon, former U.S. Senate majority leader and chair of the executive board of Cressey & Company
“…Not only is America’s continued leadership in the fight against AIDS, TB, and malaria the right thing to do, it is also the smart thing to do. … U.S. leadership on international development has laid the groundwork for mutually beneficial economic relationships around the world. It has also delivered life-saving treatment and prevention programs to poor and vulnerable communities across the globe. If we shortchange that legacy by cutting foreign aid, we risk losing our leadership position, and put millions of lives at risk. Instead, we must continue making strategic investments in foreign aid and global health, which are a clear win-win. This year, that means increasing funding to the Global Fund for its sixth funding replenishment cycle and increasing, or at the very least maintaining, funding for PEPFAR. We urge the Senate to follow the lead of their colleagues in the House and increase funding to proven solutions like the Global Fund. In doing so, we will not only help to end the epidemics of AIDS, TB, and malaria, but we will also ensure Americans continue to receive the associated economic and security benefits that make our country so great” (5/21).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.